Announced Fri, 24 Jul · 13:42 IST
Dr Lal PathLabs Q1 PAT up 27%, declares INR 5 interim dividend
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.7%1-day move
₹1690.10
prior close
₹1692.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.0+0.1+0.8+7.7—————————
Up moveDown movePending
AI summary
Dr Lal PathLabs Q1 FY27 consolidated revenue rose 19% YoY to INR 7,977 million; PAT grew 27% to INR 1,705 million. Board declared INR 5 per share interim dividend, record date July 30. Also approved 80% stake acquisition in Ghana's Sunshine Healthcare (up to INR 380 million) and 30% in Neuome Technologies (up to INR 35 million). Granted 119,300 stock options.
Likely market impact
Strong Q1 with double-digit revenue and 27% PAT growth plus dividend and international expansion. Positive for shareholders.